A phase 3 clinical trial finds the SGLT2 inhibitor canagliflozin significantly improves glycemic...
Author - Hippocrates Briefs Team
Fluorescent Probes Map Cellular Targets of GLP1R/GIPR Dual...
New fluorescent chemical tools reveal for the first time how potent dual-agonist drugs for diabetes...
Thirty-Eight-Year Analysis of Pediatric Heart Transplantation in...
A 38-year study of Nordic pediatric heart transplantation reveals a significant decline in waiting...
A Data-Driven Reclassification of Multiple Sclerosis Defines a...
A groundbreaking AI model redefines multiple sclerosis not as distinct subtypes but as a single...
Hemodynamic Impact of “Clear” E-Cigarettes with...
New research shows that "clear" e-cigarettes contain synthetic coolants and cause greater acute...
COVID-19 Associated with Accelerated Vascular Aging...
An extensive international study reveals that COVID-19 infection is linked to accelerated vascular...
Atherosclerotic Ischemia Reprograms Hematopoiesis to Promote...
New research reveals how restricted blood flow from cardiovascular disease can reprogram the immune...
Key Updates in the 2025 High Blood Pressure Guideline: New...
The new 2025 hypertension guideline updates clinical practice with the PREVENT risk calculator...
A Systematic Review of Engineering Controls for Indoor...
A central systematic review of 672 studies reveals substantial evidence gaps in how engineering...
A Systematic Review of Medication-Related Breastfeeding...
A new study reveals that many mothers are receiving incorrect advice and stopping breastfeeding...